Whitney & Company »

ResMed shares owned by Whitney & Company

Quarter-by-quarter ownership of ResMed (RMD) shares owned by Whitney & Company from 13F filings

Historical chart of Whitney & Company investment in ResMed

Tip: Access up to 7 years of quarterly data

All positions including ResMed held by Whitney & Company consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in ResMed by Whitney & Company

Quarter filed Position value Share count Share price at filing
2023-12-31 $5.0M 29k 172.02
2018-09-30 $19k 175 108.57

More positions owned by Whitney & Company

Apple (AAPL)
Microsoft Corporation (MSFT)
Fidelity Merrimack Str Tr Total Bd Etf (FBND)
Meta Platforms Cl A (META)
Ishares Tr Core S&p Ttl Stk (ITOT)
Vertex Pharmaceuticals Incorporated (VRTX)
Amazon (AMZN)
Alphabet Cap Stk Cl C (GOOG)
Charles Schwab Corporation (SCHW)
Constellation Brands Cl A (STZ)
JPMorgan Chase & Co. (JPM)
Doubleline Etf Trust Opportunistic Bd (DBND)
Adobe Systems Incorporated (ADBE)
Cigna Corp (CI)
Select Sector Spdr Tr Energy (XLE)

View all positions for Whitney & Company

Top funds holding ResMed

Vanguard Group
Bank of New York Mellon
Norges Bank Investment Management
Legal & General Group
Charles Schwab Investment Management
Jpmorgan Chase & Co
Goldman Sachs Group
Lgt Capital Partners
Amundi
Ubs Global Asset Management Americas
Congress Asset Management
Zurich Insurance Group Ltd/FI
Dimensional Fund Advisors
Citadel Advisors
Jane Street

View all funds holding ResMed